Reply to the Letter to the Editor 'Radiation therapy for locally advanced pancreatic adenocarcinoma: a therapeutic option which should not be forgotten' (in regard to "Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and followup")

被引：0
|
作者：
Conroy, T. [1 ,2 ]
Haustermans, K. [3 ]
Ducreux, M. [4 ]
机构：
[1] Inst Cancerol Lorraine, Dept Med Oncol, Vandoeuvre les Nancy, France
[2] Univ Lorraine, Inserm INSPIIRE, Nancy, France
[3] Univ Hosp Leuven, Dept Radiat Oncol, Leuven, Belgium
[4] Univ Paris Saclay, Dept Med Oncol, Inserm Unite Dynam Cellules Tumorales, Gustave Roussy, Villejuif, France
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷 / 08期
关键词：
D O I：
10.1016/j.annonc.2024.05.004
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：750 / 751
页数：2
相关论文
共 4 条
  • [1] Radiation therapy for locally advanced pancreatic adenocarcinoma: a therapeutic option which should not be forgotten. Letter to the Editor regarding: " Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up" " by Huguet et al.
    Huguet, F.
    Bouchart, C.
    Bruynzeel, A. . M. E.
    Hawkins, M. A.
    Mukherjee, S.
    Nuyttens, J. J.
    Riou, O.
    Scorsetti, M.
    Versteijne, E.
    Loi, M.
    Vendrely, V.
    ANNALS OF ONCOLOGY, 2024, 35 (08) : 749 - 750
  • [2] Can Stereotactic Body Radiation Therapy Be a Viable and Efficient Therapeutic Option for Unresectable Locally Advanced Pancreatic Adenocarcinoma? Results of a Phase 2 Study
    Comito, Tiziana
    Cozzi, L.
    Clerici, E.
    Franzese, C.
    Tozzi, A.
    Iftode, C.
    Navarria, P.
    D'Agostino, G.
    Rimassa, L.
    Carnaghi, C.
    Personeni, N.
    Tronconi, M. C.
    De Rose, F.
    Franceschini, D.
    Ascolese, A. M.
    Fogliata, A.
    Tomatis, S.
    Santoro, A.
    Zerbi, A.
    Scorsetti, M.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2017, 16 (03) : 295 - 301
  • [3] Gemcitabine (Gem), cisplatin (Cis) and radiation therapy (RT) for patients with locally advanced pancreatic adenocarcinoma (ACA): A North Central Cancer Treatment Group (NCCTG) phase II study.
    Haddock, MG
    Swaminathan, R
    Alberts, SR
    Hauge, MD
    Foster, NR
    Martenson, JA
    Goldberg, RM
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 343S - 343S
  • [4] Safety and efficacy of stereotactic body radiation therapy combined with S-1 simultaneously followed by sequential S-1 as an initial treatment for locally advanced pancreatic cancer (SILAPANC) trial: study design and rationale of a phase II clinical trial
    Zhu, Xiaofei
    Ju, Xiaoping
    Cao, Fei
    Fang, Fang
    Qing, Shuiwang
    Shen, Yuxin
    Jia, Zhen
    Cao, Yangsen
    Zhang, Huojun
    BMJ OPEN, 2016, 6 (12):
1